Syndax Pharmaceuticals Inc (SNDX) Files Form 144 on June 1

Syndax Pharmaceuticals Inc (SNDX) submitted Form 144 on June 1. This filing indicates the potential sale of shares, typically performed by insiders or affiliates. Such filings can affect investor perception, as they may suggest insider selling, which can influence market behavior. The document's specifics and the number of shares registered have not been disclosed, making it difficult to ascertain the immediate impact on SNDX stock prices.